1. Home
  2. AMPH vs ERO Comparison

AMPH vs ERO Comparison

Compare AMPH & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • ERO
  • Stock Information
  • Founded
  • AMPH 1996
  • ERO 2016
  • Country
  • AMPH United States
  • ERO Canada
  • Employees
  • AMPH N/A
  • ERO N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • ERO
  • Sector
  • AMPH Health Care
  • ERO
  • Exchange
  • AMPH Nasdaq
  • ERO Nasdaq
  • Market Cap
  • AMPH 1.1B
  • ERO 1.3B
  • IPO Year
  • AMPH 2014
  • ERO N/A
  • Fundamental
  • Price
  • AMPH $23.71
  • ERO $15.83
  • Analyst Decision
  • AMPH Hold
  • ERO Strong Buy
  • Analyst Count
  • AMPH 5
  • ERO 1
  • Target Price
  • AMPH $38.00
  • ERO $19.00
  • AVG Volume (30 Days)
  • AMPH 466.2K
  • ERO 460.7K
  • Earning Date
  • AMPH 08-06-2025
  • ERO 07-31-2025
  • Dividend Yield
  • AMPH N/A
  • ERO N/A
  • EPS Growth
  • AMPH N/A
  • ERO N/A
  • EPS
  • AMPH 2.77
  • ERO 0.18
  • Revenue
  • AMPH $730,659,000.00
  • ERO $489,554,000.00
  • Revenue This Year
  • AMPH $0.67
  • ERO $73.94
  • Revenue Next Year
  • AMPH $5.18
  • ERO $20.16
  • P/E Ratio
  • AMPH $8.48
  • ERO $86.50
  • Revenue Growth
  • AMPH 8.05
  • ERO 13.24
  • 52 Week Low
  • AMPH $22.64
  • ERO $9.30
  • 52 Week High
  • AMPH $53.96
  • ERO $23.40
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 40.92
  • ERO 60.49
  • Support Level
  • AMPH $24.35
  • ERO $15.06
  • Resistance Level
  • AMPH $25.04
  • ERO $16.29
  • Average True Range (ATR)
  • AMPH 0.66
  • ERO 0.51
  • MACD
  • AMPH -0.22
  • ERO -0.05
  • Stochastic Oscillator
  • AMPH 7.55
  • ERO 59.24

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About ERO Ero Copper Corp.

Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.

Share on Social Networks: